Synergistic effect of pro-inflammatory TNFα and IL-17 in periostin mediated collagen deposition: Potential role in liver fibrosis

Molecular Immunology

Volumn 64, Issue 1, 2015, Pages 26-35

  Amara, Suneetha ^a   Lopez, Karina ^b   Banan, Babak ^c   Brown, Sade Kemi ^b   Whalen, Margaret ^b   Myles, Elbert ^b   Ivy, Michael T ^b   Johnson, Terrance ^b   Schey, Kevin L ^d   Tiriveedhi, Venkataswarup ^b  

^a MERCY HOSPITAL   (United States)

^b TENNESSEE STATE UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fibrosis; Inflammation; Interleukin; Periostin; Transcription factors; Tumor necrosis factor

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; INTERLEUKIN 10; INTERLEUKIN 17; MESSENGER RNA; PROTEIN C JUN; SMALL INTERFERING RNA; STAT3 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX2; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CELL ADHESION MOLECULE; DNA; POSTN PROTEIN, HUMAN; PROTEIN BINDING;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; LIVER FIBROSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; FIBROBLAST; GENETIC TRANSCRIPTION; GENETICS; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY; PROMOTER REGION;

CELL ADHESION MOLECULES; COLLAGEN TYPE I; DNA, NEOPLASM; FIBROBLASTS; HEP G2 CELLS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-17; LIVER CIRRHOSIS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-JUN; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84920080277     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.10.021     Document Type: Article

References (48)

1. Adams L.A. Biomarkers of liver fibrosis. J. Gastroenterol. Hepatol. 2011, 26:802-809.
2. Alonzi T., Maritano D., Gorgoni B., Rizzuto G., Libert C., Poli V. Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver. Mol. Cell. Biol. 2001, 21:1621-1632.
3. Argo C.K., Northup P.G., Al-Osaimi A.M., Caldwell S.H. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J. Hepatol. 2009, 51:371-379.
4. Asselah T., Bieche I., Laurendeau I., Paradis V., Vidaud D., Degott C., Martinot M., Bedossa P., Valla D., Vidaud M., Marcellin P. Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C. Gastroenterology 2005, 129:2064-2075.
5. Bataller R., Brenner D.A. Liver fibrosis. J. Clin. Invest. 2005, 115:209-218.
6. Chiricozzi A., Guttman-Yassky E., Suarez-Farinas M., Nograles K.E., Tian S., Cardinale I., Chimenti S., Krueger J.G. Integrative responses to IL-17 and TNF-alpha in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J. Invest. Dermatol. 2011, 131:677-687.
7. Cohen-Naftaly M., Friedman S.L. Current status of novel antifibrotic therapies in patients with chronic liver disease. Therap. Adv. Gastroenterol. 2011, 4:391-417.
8. Czaja A.J. Hepatic inflammation and progressive liver fibrosis in chronic liver disease. World J. Gastroenterol. 2014, 20:2515-2532.
9. Friedman S.L. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008, 134:1655-1669.
10. Gabele E., Froh M., Arteel G.E., Uesugi T., Hellerbrand C., Scholmerich J., Brenner D.A., Thurman R.G., Rippe R.A. TNFalpha is required for cholestasis-induced liver fibrosis in the mouse. Biochem. Biophys. Res. Commun. 2009, 378:348-353.
11. Gasse P., Riteau N., Vacher R., Michel M.L., Fautrel A., di Padova F., Fick L., Charron S., Lagente V., Eberl G., Le Bert M., Quesniaux V.F., Huaux F., Leite-de-Moraes M., Ryffel B., Couillin I. IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis. PLoS One 2011, 6:e23185.
12. Gines P., Cardenas A., Arroyo V., Rodes J. Management of cirrhosis and ascites. N. Engl. J. Med. 2004, 350:1646-1654.
13. Hamilton D.W. Functional role of periostin in development and wound repair: implications for connective tissue disease. J. Cell Commun. Signal. 2008, 2:9-17.
14. Hayashi H., Sakai T. Animal models for the study of liver fibrosis: new insights from knockout mouse models. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 300:G729-G738.
15. Iredale J.P. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J. Clin. Invest. 2007, 117:539-548.
16. Kluwe J., Pradere J.P., Gwak G.Y., Mencin A., De Minicis S., Osterreicher C.H., Colmenero J., Bataller R., Schwabe R.F. Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition. Gastroenterology 2010, 138:347-359.
17. Koshy P.J., Henderson N., Logan C., Life P.F., Cawston T.E., Rowan A.D. Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines. Ann. Rheum. Dis. 2002, 61:704-713.
18. Ma F.Y., Flanc R.S., Tesch G.H., Han Y., Atkins R.C., Bennett B.L., Friedman G.C., Fan J.H., Nikolic-Paterson D.J. A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis. J. Am. Soc. Nephrol. 2007, 18:472-484.
19. MacEwan D.J. TNF receptor subtype signalling: differences and cellular consequences. Cell Signal. 2002, 14:477-492.
20. Meng F., Wang K., Aoyama T., Grivennikov S.I., Paik Y., Scholten D., Cong M., Iwaisako K., Liu X., Zhang M., Osterreicher C.H., Stickel F., Ley K., Brenner D.A., Kisseleva T. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology 2012, 143:765-776. (e761-763).
21. Miyamoto M., Prause O., Sjostrand M., Laan M., Lotvall J., Linden A. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J. Immunol. 2003, 170:4665-4672.
22. Murphy S.L., Xu J., Kochanek K.D. Deaths: final data for 2010. Natl. Vital. Stat. Rep. 2010, 61:1-117.
23. Murray K.F., Carithers R.L. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology 2005, 41:1407-1432.
24. Odeh M. Pathogenesis of hepatic encephalopathy: the tumour necrosis factor-alpha theory. Eur. J. Clin. Invest. 2007, 37:291-304.
25. Odeh M., Sabo E., Srugo I., Oliven A. Relationship between tumor necrosis factor-alpha and ammonia in patients with hepatic encephalopathy due to chronic liver failure. Ann. Med. 2005, 37:603-612.
26. Oka T., Xu J., Kaiser R.A., Melendez J., Hambleton M., Sargent M.A., Lorts A., Brunskill E.W., Dorn G.W., Conway S.J., Aronow B.J., Robbins J., Molkentin J.D. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ. Res. 2007, 101:313-321.
27. Oku E., Kanaji T., Takata Y., Oshima K., Seki R., Morishige S., Imamura R., Ohtsubo K., Hashiguchi M., Osaki K., Yakushiji K., Yoshimoto K., Ogata H., Hamada H., Izuhara K., Sata M., Okamura T. Periostin and bone marrow fibrosis. Int. J. Hematol. 2008, 88:57-63.
28. Osawa Y., Hoshi M., Yasuda I., Saibara T., Moriwaki H., Kozawa O. Tumor necrosis factor-alpha promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells. PLoS One 2013, 8:e65251.
29. Prele C.M., Yao E., O'Donoghue R.J., Mutsaers S.E., Knight D.A. STAT3: a central mediator of pulmonary fibrosis?. Proc. Am. Thorac. Soc. 2012, 9:177-182.
30. Riener M.O., Fritzsche F.R., Soll C., Pestalozzi B.C., Probst-Hensch N., Clavien P.A., Jochum W., Soltermann A., Moch H., Kristiansen G. Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas. Histopathology 2010, 56:600-606.
31. Rosenberg W.M., Voelker M., Thiel R., Becka M., Burt A., Schuppan D., Hubscher S., Roskams T., Pinzani M., Arthur M.J. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004, 127:1704-1713.
32. Ruan K., Bao S., Ouyang G. The multifaceted role of periostin in tumorigenesis. Cell. Mol. Life. Sci. 2009, 66:2219-2230.
33. Sarma N.J., Tiriveedhi V., Crippin J.S., Chapman W.C., Mohanakumar T. Hepatitis C virus-induced changes in microRNA 107 (miRNA-107) and miRNA-449a modulate CCL2 by targeting the interleukin-6 receptor complex in hepatitis. J. Virol. 2014, 88:3733-3743.
34. Schuppan D., Afdhal N.H. Liver cirrhosis. Lancet 2008, 371:838-851.
35. Sidhu S.S., Yuan S., Innes A.L., Kerr S., Woodruff P.G., Hou L., Muller S.J., Fahy J.V. Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:14170-14175.
36. Sudo K., Yamada Y., Moriwaki H., Saito K., Seishima M. Lack of tumor necrosis factor receptor type 1 inhibits liver fibrosis induced by carbon tetrachloride in mice. Cytokine 2005, 29:236-244.
37. Takayama G., Arima K., Kanaji T., Toda S., Tanaka H., Shoji S., McKenzie A.N., Nagai H., Hotokebuchi T., Izuhara K. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J. Allergy Clin. Immunol. 2006, 118:98-104.
38. Tang Y., Bian Z., Zhao L., Liu Y., Liang S., Wang Q., Han X., Peng Y., Chen X., Shen L., Qiu D., Li Z., Ma X. Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease. Clin. Exp. Immunol. 2011, 166:281-290.
39. Theiss A.L., Simmons J.G., Jobin C., Lund P.K. Tumor necrosis factor (TNF) alpha increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2. J. Biol. Chem. 2005, 280:36099-36109.
40. Tilg H., Kaser A., Moschen A.R. How to modulate inflammatory cytokines in liver diseases. Liver Int. 2006, 26:1029-1039.
41. Tiriveedhi V., Gelman A.E., Mohanakumar T. HIF-1alpha signaling by airway epithelial cell K-alpha1-tubulin: role in fibrosis and chronic rejection of human lung allografts. Cell. Immunol. 2012, 273:59-66.
42. Tiriveedhi V., Takenaka M., Ramachandran S., Gelman A.E., Subramanian V., Patterson G.A., Mohanakumar T. T regulatory cells play a significant role in modulating MHC class I antibody-induced obliterative airway disease. Am. J. Transplant. 2012, 12:2663-2674.
43. Verrecchia F., Wagner E.F., Mauviel A. Distinct involvement of the Jun-N-terminal kinase and NF-kappaB pathways in the repression of the human COL1A2 gene by TNF-alpha. EMBO Rep. 2002, 3:1069-1074.
44. Woodruff P.G., Boushey H.A., Dolganov G.M., Barker C.S., Yang Y.H., Donnelly S., Ellwanger A., Sidhu S.S., Dao-Pick T.P., Pantoja C., Erle D.J., Yamamoto K.R., Fahy J.V. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:15858-15863.
45. Woodruff P.G., Modrek B., Choy D.F., Jia G., Abbas A.R., Ellwanger A., Koth L.L., Arron J.R., Fahy J.V. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am. J. Respir. Crit. Care Med. 2009, 180:388-395.
46. Xu R., Zhang Z., Wang F.S. Liver fibrosis: mechanisms of immune-mediated liver injury. Cell. Mol. Immunol. 2012, 9:296-301.
47. Zhu F., Wang Q., Guo C., Wang X., Cao X., Shi Y., Gao F., Ma C., Zhang L. IL-17 induces apoptosis of vascular endothelial cells: a potential mechanism for human acute coronary syndrome. Clin. Immunol. 2011, 141:152-160.
48. Zimmermann H.W., Trautwein C., Tacke F. Functional role of monocytes and macrophages for the inflammatory response in acute liver injury. Front. Physiol. 2012, 3:56.